Discover B2B companies, suppliers, and manufacturers related to this keyword category
A novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line (PDC*line)
Altevax is developing a disruptive immunotherapy technology against cancer